(PharmaNewsWire.Com, August 01, 2019 ) The report "Sustained Release Coatings Market by Application (In Vitro, In Vivo), Substrate Type (Tablets, Capsules, Pills), Polymer Material Type (Ethyl & Methyl Cellulose, Polyvinyl & Cellulose Acetate, Methacrylic Acid, PEG), and Region - Global Forecast to 2024" The sustained release coating market size is projected to grow from USD 478 million in 2019 to USD 660 million by 2024, at a CAGR of 6.6% during the forecast period.
In Vitro is estimated to be the largest application of sustained release coating during the forecast period.
The In Vitro segment is the largest application of sustained release coating market and is expected to continue till 2024. The market in the In Vitro application is driven by the continuous expenditure of the pharmaceutical companies in their R&D. The In Vitro application areas are pharmaceutical companies’ R&D domain, government laboratories, contract research organizations, and many private research organizations. Ethyl & methyl cellulose and PEG are the major polymer type materials, which are used mostly for In Vitro applications.
Browse in-depth TOC on "Sustained Release Coatings Market” 63 - Market Data Tables 24 - Figures 93 - Pages
North America is estimated to be the largest market for sustained release coating during the forecast period.
North America is estimated to account for the largest share of the sustained release coating market during the forecast period. The demand for sustained release coating is increasing due to the presence of pharmaceutical manufacturers in the region. The region’s annual growth in R&D spending indicates a period of stability, security, and healthy competition. With the presence of a large number of global pharmaceutical giants such as Pfizer (US), Abbott Laboratories (US), and Johnson & Johnson (US) in North America and huge investments for the development of novel drugs and drug delivery systems, the sustained released coating market is expected to grow at a stable rate over the forecast period.
The key players in this market include Colorcon (US), BASF (Germany), Evonik (Germany), and Coating Place (US).
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the “Growth Engagement Model – GEM”. The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write “Attack, avoid and defend” strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, “Knowledge Store” connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
